Wound Bed Preparation: The TIME Framework Explained

Wound Bed Preparation and the TIME Framework

Wound bed preparation is the systematic approach to managing a chronic wound so that the biological environment supports healing rather than perpetuating stagnation. The concept was formalized in 2003 by Schultz et al. and has since become the foundation of evidence-based wound management worldwide. At its core, wound bed preparation addresses the gap between what a wound needs to heal and what the wound environment is actually providing.

The TIME framework translates wound bed preparation into four actionable clinical domains: Tissue management, Infection and inflammation control, Moisture balance, and Edge advancement. Each domain represents a barrier to healing that must be assessed and addressed at every visit. When clinicians skip one domain or treat them in isolation, the wound stalls. When all four are addressed systematically, healing rates improve and unnecessary advanced therapies are avoided.

T — Tissue Management: Removing the Barriers

Non-viable tissue in the wound bed is the most visible obstacle to healing. Necrotic tissue, slough, and devitalized tissue harbor bacteria, prevent accurate wound assessment, and physically block granulation tissue from forming. Tissue management is therefore the first step in wound bed preparation.

Debridement Methods and Selection

The choice of debridement method depends on wound type, tissue characteristics, patient tolerance, and clinical setting:

Sharp/surgical debridement is the gold standard for removing thick eschar or adherent necrotic tissue. It provides immediate results, allows wound bed assessment, and is billable under CPT codes 97597-97598 (selective) or 11042-11047 (excisional). This is the most common debridement method used in mobile wound care.

Autolytic debridement uses the body's own enzymes under moisture-retentive dressings. It is painless and selective but slow — appropriate for patients who cannot tolerate sharp debridement or when necrotic burden is minimal.

Enzymatic debridement (collagenase/Santyl) breaks down collagen in necrotic tissue. It requires a prescription and daily application, making it most practical when patients or caregivers can manage dressing changes between visits.

Mechanical debridement includes wet-to-dry dressings (largely fallen out of favor due to non-selectivity and pain), pulsed lavage, and low-frequency ultrasound. Pulsed lavage is effective for large wounds with heavy biofilm burden.

The documentation standard for tissue management: describe the tissue type removed, the method used, the percentage of wound bed affected before and after debridement, and the clinical rationale for the chosen method.

I — Infection and Inflammation Control

Chronic wounds exist on a continuum from contamination (all wounds have bacteria) through colonization, critical colonization (biofilm), local infection, and systemic infection. The clinical challenge is distinguishing between colonization — which requires no antibiotic treatment — and critical colonization or infection, which demands intervention.

Recognizing the Biofilm Continuum

Biofilm is present in an estimated 60-80% of chronic wounds. It is not always visible to the naked eye. Clinical signs of biofilm and critical colonization include:

Wound stalling despite appropriate treatment for 2-4 weeks
Friable or hypergranulation tissue that bleeds easily
Increased exudate without other signs of infection
Low-grade periwound erythema that does not meet cellulitis criteria
Recurrent breakdown after apparent epithelialization

Classic infection signs — purulence, expanding erythema, warmth, pain, and fever — are easier to identify but often represent a later stage. The goal is to catch the wound at the biofilm/critical colonization stage before systemic infection develops.

For a deeper dive into biofilm detection and treatment strategies, see our guide on wound care biofilm management.

Treatment Approach

The evidence supports a "cleanse, debride, treat" sequence:

Cleanse with an antiseptic wound cleanser (polyhexanide, hypochlorous acid, or dilute sodium hypochlorite)
Debride to physically disrupt biofilm architecture
Treat with topical antimicrobials (silver dressings, cadexomer iodine, or medical-grade honey) for 2-4 weeks

Systemic antibiotics are reserved for wounds with clinical signs of local or systemic infection. They do not penetrate biofilm effectively and should not be used as a substitute for local wound bed preparation.

M — Moisture Balance: The Goldilocks Principle

Wound healing requires a moist environment — this has been established since Winter's landmark 1962 research. However, excess moisture is equally harmful. Maceration of periwound skin from excessive exudate breaks down intact tissue and expands the wound. The goal is a wound environment that is moist but not wet.

Matching Dressings to Exudate

Dressing selection is primarily driven by exudate management:

Exudate Level	Dressing Category	Examples
None to minimal	Moisture-donating	Hydrogels, honey-based dressings
Minimal to moderate	Moisture-retentive	Foam dressings, hydrofiber
Moderate to heavy	Absorptive	Alginate, superabsorbent polymers
Heavy	Highly absorptive	Superabsorbent dressings, NPWT

Periwound skin protection is part of moisture balance. Barrier creams, skin protectants, or liquid skin barriers should be applied to intact periwound tissue at every dressing change when exudate is moderate or greater.

Document the exudate amount (none, scant, small, moderate, large, copious), color, consistency, and odor. Also document the dressing selected and the clinical rationale linking dressing choice to exudate management. For detailed protocols on dressing selection by exudate level, see our wound moisture balance guide.

E — Edge Advancement: Measuring Progress

Edge advancement is the measurable outcome that confirms the other three TIME components are working. If tissue is managed, infection is controlled, and moisture is balanced, the wound edges should be migrating inward. When they are not, one or more of the other domains is inadequately addressed.

The 4-Week Assessment Rule

The widely cited benchmark: a chronic wound should demonstrate at least 40-50% reduction in surface area within 4 weeks of appropriate treatment to be on a trajectory toward closure. Wounds that fail to meet this threshold require reassessment of the entire TIME framework and consideration of advanced therapies.

This 4-week rule is also a Medicare documentation trigger. Continued treatment of a wound that shows no measurable progress requires documented clinical rationale for why the current treatment plan should continue — or a documented change in the plan.

Undermining and Tunneling

Non-advancing edges sometimes indicate undermining (a pocket between the wound base and the wound edge) or tunneling (a narrow channel extending from the wound). Both must be measured and documented at every visit using a probe or cotton-tipped applicator, recorded as clock-face positions with depth.

Undermining and tunneling are not just measurement variables — they change the treatment plan. Wounds with significant undermining may require packing, negative pressure wound therapy, or surgical intervention. Failing to document them can result in undertreatment and missed billing opportunities.

When Edges Stall

When wound edges are not advancing despite 4 weeks of appropriate TIME-based management, the clinician should consider:

Undiagnosed arterial insufficiency (check ABI if not already performed)
Uncontrolled diabetes (A1c > 8% significantly impairs healing)
Nutritional deficiency (prealbumin < 15 mg/dL indicates protein malnutrition)
Medication interference (corticosteroids, immunosuppressants, some chemotherapy agents)
Biofilm recurrence (debride and restart antimicrobial protocol)
Need for advanced therapies (skin substitutes, growth factors, hyperbaric oxygen)

Putting the TIME Framework Into Practice

The TIME framework is not a one-time assessment. It is a dynamic evaluation performed at every wound care visit. Each component informs the others:

A wound that is debrided (T) but not treated for biofilm (I) will re-accumulate necrotic tissue
A wound with perfect moisture balance (M) but residual necrotic tissue (T) will not granulate
A wound showing edge advancement (E) confirms that T, I, and M are adequately managed

The documentation discipline that TIME enforces — describing tissue type, infection status, moisture level, and edge behavior at every visit — also builds the medical necessity narrative that payers require for continued treatment authorization.

Key Takeaways

The TIME framework provides a systematic, repeatable wound bed preparation protocol — tissue management, infection control, moisture balance, and edge advancement must all be assessed at every visit
Biofilm is present in 60-80% of chronic wounds and requires physical disruption through debridement plus topical antimicrobials, not systemic antibiotics alone
Dressing selection should be driven by exudate level, matching absorptive capacity to wound output while protecting periwound skin from maceration
The 4-week rule (40-50% area reduction) is both a clinical benchmark and a Medicare documentation trigger — wounds that stall require reassessment of all TIME domains before escalating to advanced therapies
Edge advancement is the measurable proof that wound bed preparation is working — when edges stall, investigate systemic factors (vascular status, glycemic control, nutrition) before assuming the local treatment plan has failed